Pegasys 180 MCG/0.5 ML syringe 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26FCW0A
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $17,403
Award facts
- Contract value 100% obligated
- $17,402.52 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp, a leading pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a delivery order award from the Defense Logistics Agency (DLA) on December 19, 2025, valued at $17,402.52 for Pegasys 180 mcg/0.5 mL syringes. This firm fixed-price delivery order is a child contract under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026. The award is non-set-aside and was competitively awarded, reflecting the contractor's demonstrated capability to meet federal pharmaceutical procurement requirements. Performance will be completed by December 22, 2025, at the company's Conshohocken facility.
AmerisourceBergen's prime contract with DLA serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a vast range of medications, vaccines, medical devices, and specialized healthcare commodities to support military healthcare programs worldwide. The company's extensive federal contracting history demonstrates its role as a critical vendor for Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. This particular delivery order for Pegasys, an interferon-based antiviral medication, exemplifies the breadth of pharmaceutical products the contractor furnishes under its DLA agreement to support military medical readiness and treatment needs.
Quick answers
Who was awarded contract SPE2DR26FCW0A?
SPE2DR26FCW0A was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 19, 2025.
How much is contract SPE2DR26FCW0A worth?
The government has obligated $17,403 on SPE2DR26FCW0A.
Is contract SPE2DR26FCW0A an order under another contract?
Yes. SPE2DR26FCW0A is a delivery order under SPE2DR25D1100, an indefinite delivery contract.
Was contract SPE2DR26FCW0A competed?
The extent of competition for SPE2DR26FCW0A was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award